Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion type Assertion NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_head.
- NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion description "[By contrast, 10 of 62 (16%) SK revealed the typical cancer-associated PIK3CA mutations E542K, E545K, and H1047R.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_provenance.
- NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion evidence source_evidence_literature NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_provenance.
- NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion SIO_000772 17673550 NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_provenance.
- NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion wasDerivedFrom befree-20140225 NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_provenance.
- NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_assertion wasGeneratedBy ECO_0000203 NP287621.RANOZAoxhYB4izau3hTjJRV_bHcWGKwFQZcU1zGi_l-Qg130_provenance.